Product
BNT164b1
2 clinical trials
1 indication
Indication
TuberculosisClinical trial
A Phase Ia, Randomized, Placebo-controlled, Double-blind, Dose-finding Evaluation Trial to Describe the Safety, Reactogenicity, and Immunogenicity of Two Investigational Vaccines Against Tuberculosis in IGRA-negative, BCG naïve SubjectsStatus: Recruiting, Estimated PCD: 2024-09-01
Clinical trial
A Phase Ib/IIa Two-part, Randomized, Placebo-controlled, Observer-blind, Dose-finding Evaluation Trial to Describe the Safety, Reactogenicity, and Immunogenicity of Two Investigational Vaccines Against Tuberculosis in BCG Vaccinated, HIV-negative Subjects and People Living With HIVStatus: Recruiting, Estimated PCD: 2026-03-01